Aldeyra Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
19.88
|
|
Average Rating
|
4.71
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.34
|
-0.25
|
0.09
|
26.47%
|
|
2022-06-30
|
-0.31
|
-0.30
|
0.01
|
3.23%
|
|
2022-03-31
|
-0.31
|
-0.29
|
0.02
|
6.45%
|
|
2021-12-31
|
-0.28
|
-0.27
|
0.01
|
3.57%
|
|
2021-09-30
|
-0.26
|
-0.27
|
-0.01
|
-3.85%
|
|
2021-06-30
|
-0.24
|
-0.28
|
-0.04
|
-16.67%
|
|
2021-03-31
|
-0.27
|
-0.25
|
0.02
|
7.41%
|
|
2020-12-31
|
-0.28
|
-0.30
|
-0.02
|
-7.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.84
|
|
2021-12-31
|
-1.07
|
|
2020-12-31
|
-1.12
|
|
2019-12-31
|
-2.23
|
|
2018-12-31
|
-1.90
|
|
2017-12-31
|
-1.40
|
|
2016-12-31
|
-1.67
|
|
2015-12-31
|
-1.40
|
|
2014-12-31
|
-2.40
|